Document is current
Any future updates will be listed below
-
Authors
Novak, Peter https://orcid.org/0000-0002-5971-1208
- License Information
-
More Information
Article History
Received: 4 September 2023
Accepted: 21 October 2023
First Online: 3 November 2023
Change Date: 8 March 2024
Change Type: Update
Change Details: The topical collection tagging has been removed for this article.
Declarations
:
: The study was approved by the BWH Institutional Review Board as a minimal-risk study.
: Dr. Novak is an advisor-independent contractor for the Dysimmune Diseases Foundation. Dr. Novak owns or owned stocks or stock options for Pfizer, Moderna, Editas Medicine, and Novavax. Dr. Novak received royalties from Oxford University Press.
